// App-Quantinova.ai

: - GMNC risk alleles in individuals with Alzheimer’s disease are associated with cerebrospinal fluid concentrations of proteins involved in neuronal plasticity and blood brain barrier function

Researchers

Presenter

  • Pieter Jelle Visser

Principal Investigators

  • Lianne M. Reus

  • Johan Gobom

  • Charlotte E. Teunissen

  • Lars Bertram

  • Henrik Zetterberg

  • Betty M. Tijms

Medical Centers

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

  • Department of Neurodegenerative Disease, UCL Institute of Neurology

  • Alzheimer Center Amsterdam, Amsterdam UMC

  • University of Lubeck,

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC

  • Neurochemistry Laboratory, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

  • Hong Kong Center for Neurodegenerative Diseases

  • Karolinska Institutet,

  • Alzheimer Centrum Limburg, Maastricht University

Locations

  • United States

  • United Kingdom

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved